Skip to main content
Erschienen in: Acta Neuropathologica 5/2019

12.09.2019 | Correspondence

Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas

verfasst von: Emily A. Sloan, Tabitha Cooney, Nancy Ann Oberheim Bush, Robin Buerki, Jennie Taylor, Jennifer L. Clarke, Joseph Torkildson, Cassie Kline, Alyssa Reddy, Sabine Mueller, Anu Banerjee, Nicholas Butowski, Susan Chang, Praveen V. Mummaneni, Dean Chou, Lee Tan, Philip Theodosopoulos, Michael McDermott, Mitchel Berger, Corey Raffel, Nalin Gupta, Peter P. Sun, Yi Li, Vinil Shah, Soonmee Cha, Steve Braunstein, David R. Raleigh, David Samuel, David Scharnhorst, Cynthia Fata, Hua Guo, Gregory Moes, John Y. H. Kim, Carl Koschmann, Jessica Van Ziffle, Courtney Onodera, Patrick Devine, James P. Grenert, Julieann C. Lee, Melike Pekmezci, Joanna J. Phillips, Tarik Tihan, Andrew W. Bollen, Arie Perry, David A. Solomon

Erschienen in: Acta Neuropathologica | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Excerpt

Somatic mutations in the H3F3A and HIST1H3B genes encoding the histone H3 variants H3.3 and H3.1, respectively, are important genetic drivers of diffuse gliomas in both children and adults. The recurrent p.K27M mutation in either H3F3A or HIST1H3B genes is found in the majority of diffuse gliomas centered in midline structures of the central nervous system including the thalamus, brainstem, and spinal cord where it is associated with poor prognosis irrespective of histologic grade [911]. “Diffuse midline glioma, H3 K27M-mutant” was thus classified as a grade IV entity in the revised 2016 WHO Classification of Tumors of the Central Nervous System. In contrast, p.G34R or p.G34V mutation in the H3F3A gene is found in a subset of glioblastomas located in the cerebral hemispheres of adolescents and young adults and is associated with a more favorable prognosis [6, 810]. While the genetic landscape of supratentorial and brainstem gliomas has now been extensively characterized [9, 11], the genetic drivers of spinal cord diffuse gliomas are less understood [1]. Here we report genomic characterization of 13 spinal cord diffuse gliomas that identified recurrent non-canonical histone H3 mutations including H3F3A p.G34W and H3F3B p.K27I variants. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D et al (2017) H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol 41:1059–1068CrossRefPubMedPubMedCentral Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D et al (2017) H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol 41:1059–1068CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P et al (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45:1479–1482CrossRefPubMed Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P et al (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45:1479–1482CrossRefPubMed
4.
Zurück zum Zitat Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M et al (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27:985–990CrossRefPubMedPubMedCentral Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M et al (2013) The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 27:985–990CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Cleven AH, Hocker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovee JV (2015) Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39:1576–1583CrossRefPubMed Cleven AH, Hocker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovee JV (2015) Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol 39:1576–1583CrossRefPubMed
6.
Zurück zum Zitat Gessi M, Gielen GH, Hammes J, Dorner E, Muhlen AZ, Waha A et al (2013) H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? J Neurooncol 112:67–72CrossRefPubMed Gessi M, Gielen GH, Hammes J, Dorner E, Muhlen AZ, Waha A et al (2013) H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? J Neurooncol 112:67–72CrossRefPubMed
7.
Zurück zum Zitat Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol 19:699–709PubMed Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C et al (2017) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol 19:699–709PubMed
8.
Zurück zum Zitat Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V et al (2016) Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131:137–146CrossRefPubMed Korshunov A, Capper D, Reuss D, Schrimpf D, Ryzhova M, Hovestadt V et al (2016) Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity. Acta Neuropathol 131:137–146CrossRefPubMed
9.
Zurück zum Zitat Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520–537CrossRefPubMedPubMedCentral Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520–537CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437CrossRefPubMed Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437CrossRefPubMed
11.
Zurück zum Zitat Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444–450CrossRefPubMedPubMedCentral Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46:444–450CrossRefPubMedPubMedCentral
Metadaten
Titel
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas
verfasst von
Emily A. Sloan
Tabitha Cooney
Nancy Ann Oberheim Bush
Robin Buerki
Jennie Taylor
Jennifer L. Clarke
Joseph Torkildson
Cassie Kline
Alyssa Reddy
Sabine Mueller
Anu Banerjee
Nicholas Butowski
Susan Chang
Praveen V. Mummaneni
Dean Chou
Lee Tan
Philip Theodosopoulos
Michael McDermott
Mitchel Berger
Corey Raffel
Nalin Gupta
Peter P. Sun
Yi Li
Vinil Shah
Soonmee Cha
Steve Braunstein
David R. Raleigh
David Samuel
David Scharnhorst
Cynthia Fata
Hua Guo
Gregory Moes
John Y. H. Kim
Carl Koschmann
Jessica Van Ziffle
Courtney Onodera
Patrick Devine
James P. Grenert
Julieann C. Lee
Melike Pekmezci
Joanna J. Phillips
Tarik Tihan
Andrew W. Bollen
Arie Perry
David A. Solomon
Publikationsdatum
12.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Acta Neuropathologica / Ausgabe 5/2019
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-019-02072-2

Weitere Artikel der Ausgabe 5/2019

Acta Neuropathologica 5/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.